|
ZNHIT6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.360300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.252830E-01 |
| Normal-vs-Stage2 |
7.947500E-02 |
| Normal-vs-Stage3 |
2.627900E-02 |
| Normal-vs-Stage4 |
5.382700E-03 |
| Stage1-vs-Stage2 |
4.156600E-01 |
| Stage1-vs-Stage3 |
1.749390E-01 |
| Stage1-vs-Stage4 |
3.274000E-02 |
| Stage2-vs-Stage3 |
9.680800E-01 |
| Stage2-vs-Stage4 |
5.313400E-01 |
| Stage3-vs-Stage4 |
4.160600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.724200E-02 |
| Normal-vs-AfricanAmerican |
1.094370E-02 |
| Normal-vs-Asian |
4.991000E-01 |
| Caucasian-vs-AfricanAmerican |
1.824800E-01 |
| Caucasian-vs-Asian |
5.941600E-02 |
| AfricanAmerican-vs-Asian |
3.208100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.941720E-02 |
| Normal-vs-Female |
1.191240E-01 |
| Male-vs-Female |
1.782350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.211800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.319900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.704500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.394040E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.898600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.865600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.177950E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.990200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.228300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.736400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.865200E-01 |
| Normal-vs-Grade 2 |
3.641800E-01 |
| Normal-vs-Grade 3 |
2.899400E-03 |
| Normal-vs-Grade 4 |
6.117700E-03 |
| Grade 1-vs-Grade 2 |
5.502000E-01 |
| Grade 1-vs-Grade 3 |
1.619910E-02 |
| Grade 1-vs-Grade 4 |
4.718000E-02 |
| Grade 2-vs-Grade 3 |
9.69039999999532E-05 |
| Grade 2-vs-Grade 4 |
5.542200E-03 |
| Grade 3-vs-Grade 4 |
7.808200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.659200E-01 |
| Normal-vs-ccB subtype |
1.429730E-02 |
| ccA subtype-vs-ccB subtype |
9.096900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.304200E-02 |
| Normal-vs-N1 |
1.781200E-01 |
| N0-vs-N1 |
6.583800E-01 |
|
|
